XF Microlens Optic and XD Microlens Compression Optic for Non-Ablative Fractional Skin Treatment with the Palomar Icon System

Similar documents
Palomar Icon 1540 Fractional Laser. Fractional Non-Ablative Skin Resurfacing

Introduction. Device Description. Dual-Band Spectral Output

FEB-2015 ISSUE. Dr. David Pudukadan

Icon specifications. Handpiece compatibility

Daryl Mossburg, BSN RN Clinical Specialist Sciton, Inc.

In Vivo Histological Evaluation of a Novel YSGG Ablative Fractional Device for Cutaneous Remodeling

StarLux Fractional Non-Ablative Skin Resurfacing

Dual wavelength (1540nm nm) mixed technology for fractional resurfacing in skin rejuvenation Background

In-vivo histopathological study of YouLaser MT interaction with the skin. A laser device emitting combined 1540 and nm wavelengths.

Micro-island damage with a nonablative 1540-nm Er:Glass fractional laser device in human skin

High Power CO2 Laser + Micro-needle Fractional RF

PHYSICIANS GUIDE. Understanding Fraxel TM Laser Treatment

ProFractional. ProFractional Therapy. Tunable Fractional Solution. Advanced Fractional Aesthetic Laser Surgery

SPECIAL TOPIC. AboutSkin Dermatology & DermSurgery, Greenwood Village, CO b. The Aesthetic Clinique, Destin, FL c

Aesthetic Laser Industry Why the excitement?

Non-Ablative Rejuvenation

Diode Lasers Enable Diverse Therapeutic Applications

NO MORE NEWS AN EVIDENCE BASED APPROACH ON LASERS IN SKIN OF COLOR PATIENTS DR. EDUARDO WEISS, M.D., FAAD

MultiPulse PRO - CO 2 Laser -

LASERS: CAN THEY TREAT SPIDER VEINS? Steven E. Zimmet, MD

CLINICAL EVALUATION REPORT ON THE EFFICACY AND SAFETY OF THE CORE SYSTEM FOR FACIAL ENHANCEMENT TREATMENTS

Superior RF Multi-Treatment Platform

Superior RF Multi-Treatment Platform

Arisa Ortiz, MD Director, Laser and Cosmetic Dermatology Assistant Clinical Professor Department of Dermatology UC San Diego

Clinical Efficacy and Statistical Evaluation of INTRAcel Treatment

An In-Depth Examination of Radiofrequency Assisted Liposuction (RFAL)

UltraPulse Encore. Bridge Therapy Fractional CO 2.

Hands-on: Lasers. NonAblative Rejuvenation

Evaluation of the wound healing response post - deep dermal heating by fractional RF: INTRACEL

Evaluation of the wound healing response post deep dermal heating by fractional RF: INTRAcel

Five Parameters You Must Understand to Master Control of Your Laser/Light-Based Devices

The use of light as a medical treatment has SPECIAL TOPIC. Fractional Photothermolysis for Skin Rejuvenation.

NEW IN-DEMAND AESTHETICS IN ONE PLATFORM TECH BREAKTHROUGH PLUS

NEOGENEVO ENERGIST NITROGEN PLASMA SYSTEM SKIN RESURFACING SKIN REJUVENATION SKIN TIGHTENING SKIN REGENERATION SEVERE AND FINE WRINKLE REDUCTION

Diffusers Beam Splitters Refractive Microlens Arrays

Mona SC-2 Ultra Pulse Co2 Fractional laser system. Beijing Sanhe Beauty S & T Co.,Ltd

Multi-Application Platform. Summary of Peer-reviewed Articles for Various Clinical Indications April 2016

Presentation Product & clinics

NONABLATIVE RESURFACING

Laser Treatment of Leg Veins

Fractional treatment of aging skin with Tixel, a clinical and histological evaluation

NOVEL MULTI-SOURCE PHASE-CONTROLLED RADIOFREQUENCY TECHNOLOGY FOR NON- ABLATIVE AND MICRO-ABLATIVE TREATMENT OF WRINKLES, LAX SKIN AND ACNE SCARS

Laser Effects on Skin Melanin

LASER TREATMENT PEARLS FOR PHOTO-REJUVENATION

BISON. Accento. 755nm Long Pulsed Alexandrite Laser 1064nm Long Pulsed Nd:YAG Laser FOR EXPORT ONLY

Citation for published version (APA): van Drooge, A. M. (2014). Improvement of disfiguring skin conditions by laser therapy

Be an artist of the new

Light EVO. Taking care of people, our masterpieces. Multiple Wavelengths for the Highest Challenges in Laser Applications.

Treatment of periorbital wrinkles with 1,550 and 1,565 nm Er:Glass fractional photothermolysis lasers: A simultaneous split-face trial

MCL31 Dermablate THE WORLD S MOST SUCCESSFUL ERBIUM:YAG LASER FOR AESTHETIC MEDICINE

Physician s Clinical Guideline

Information and Consent For Intracel

Diode and diode pumped frequencies doubled solid state. 940 nm, 532 nm

M & T srl. medical & technology

BBLs BroadBand Light. Daryl Mossburg, RN BSN Clinical Specialist Sciton, Inc. All rights reserved.

Assisting diagnosis of melanoma through the noninvasive biopsy of skin lesions

Ultra Skin Needling. Rejuvenate Supports Collagen Regeneration Scar Improvement. For your best ever skin.

Laser and Pulse Electromagnetic Field Therapies. By Jenna MacDonell, DVM,CVA

Using Normal and High Pulse Coverage With Picosecond Laser Treatment of Wrinkles and Acne Scarring: Long Term Clinical Observations

LIGHT SERIES MULTIPLE WAVELENGTHS FOR THE HIGHEST CHALLENGES IN LASER APPLICATIONS

The breast advice for managing radiotherapy induced skin reactions

Perfect skin with cosmetic mole removal

Skin Responses to Fractional Photothermolysis

Laser Skin Rejuvenation

MCL 30. MCL 30 Dermablate Fractional Er:YAG (with MICROSPOT EXTENSION SET) EN 1

COMBINING RADIOFREQUENCY SYSTEMS. to treat the neck BALANCING METHYLATION AGEING AND DISEASE PREVENTION TREATING STRETCH MARKS A LITERATURE REVIEW

From the Standpoint of Dermatology

A novel fractional micro-plasma radio-frequency technology for the treatment of facial scars and rhytids: A pilot study

MULTI PLATFORM SOLUTION FOR FEMININE HEALTH CONCERNS

Laser Skin Rejuvenation

A Clinical, Histological, and Computer-Based Assessment of the Polaris LV, Combination Diode, and Radiofrequency System, for Leg Vein Treatment

NEOGEN Evo ENE RGI ST NITROGEN PLASMA SYSTEM ARTG SKIN RESURFACING SKIN REGENERATION SOFT BLEPHAROPLASTY MELASMA SKIN TIGHTENING

Treatment of Leg Telangiectasia (Spider Veins) with Magma Long Pulse ND - Laser 1064 nm Case Study

Treat Your Patients Better

Asian skin rejuvenation with PicoFractional laser

Available online at Vol. 07, No. 02, pp , February, 2018 RESEARCH ARTICLE

Change the story your skin is telling!

M u l t i - A p p l i c a t i o n L a s e r S y s t e m

PROVIDER ACCREDITATION

In Vivo Histological Evaluation of a Novel Ablative Fractional Resurfacing Device

The LiteTouch Edge. Innovative Energy Delivery

Clinical experiences in Asian skin with new technology of ablative fractional Er:YAG Laser

Just the Facts Ma am

Histopathology of Laser Skin Resurfacing

Chapter 21: FotoFacial RF Pro Treatment of Specific Clinical Subtypes

Non-ablative Acne Scar Reduction with a Short-Pulsed 1064-nm Nd:YAG Laser a Pilot Study

VivoSight Imaging for Dermatologists

LOOKING INTO SKIN FOR BETTER RESULTS

Disclosures. Laser Treatment of Scars. Options for Cutaneous Scarring. Laser Treatment of Erythematous Scars. Laser Scar Revision Scar Type

Personalized Body Sculpting: The Next Evolution

Efficacy of minimally invasive nonthermal laser-induced optical breakdown technology for skin rejuvenation

HISTOLOGICAL EVALUATION AFTER RADIOFREQUENCY TREATMENT FOR FACE REJUVENATION AND CELLULITIS

Clinical Study Treatment of Mesh Skin Grafted Scars Using a Plasma Skin Regeneration System

EXPERIMENTAL THERMAL BURNS I. A study of the immediate and delayed histopathological changes of the skin.

Treatment of Postpartum Leg Telangiectasia (Spider Veins) with Magma Long Pulse ND - Laser 1064 nm Case Study

Review of Fractional Photothermolysis: Treatment Indications and Efficacy

Casnigo, April, the 21 st, Operative Protocols for PRISMA Nd: YAG laser 1440

Hybrid Energy TM Technology

GAFCHROMIC MD-55 RADIOCHROMIC DOSIMETRY FILM FOR HIGH-ENERGY PHOTONS CONFIGURATION, SPECIFICATIONS AND PERFORMANCE DATA

Reports on Scientific Meeting

Transcription:

Optic and XD Microlens Compression Optic for Non-Ablative Fractional Skin Treatment with the Palomar Icon System Sean Doherty, M.D., 1 Brooke Seckel, M.D., 1 James Childs Ph.D., 2 David Tabatadze Ph.D., 2 Andrei Erofeev Ph. D., 2 Mikhail Smirnov Ph.D., 2 and Gregory Altshuler Ph.D., Sc.D. 2 1 Boston Plastic Surgery Associates, Concord, MA; 2 Palomar Medical Technologies, In., Burlington, MA Objective: Advantages of fractional non-ablative treatment over full-surface ablative treatment procedures include reduced side effects, downtime, and patient discomfort. We describe two novel non-ablative fractional optics that expand upon these advantages by providing faster treatment coverage and deeper coagulation depths with minimized epidermal involvement as compared to previous-generation optics. Conclusions: The Optic provides fast high-coverage fractional treatment with coagulation depths that extend into the reticular dermis. The XD Microlens utilizes compression optics to deliver microbeam energy to deep portions of the dermis and the dermal/hypodermal (D/H) junction causing coagulated micro-columns over 1 mm in depth. Clinical experiences with both devices have demonstrated dermal remodeling and good results for the indications of striae, surgical scars, and acne scars. Introduction Fractional methods of non-ablative skin resurfacing generate micro-columns of thermal damage in the dermis resulting in controlled wound healing with minimal side effects and recovery time. Given the favorable safety profile of this technology, efforts are ongoing to further improve the efficacy and applicability of fractional resurfacing. From the practitioner s perspective, two areas with room for improvement are the speed and depth of resurfacing treatments. Addressing the former would enable more efficient treatment of larger anatomical areas while addressing the latter would provide better clinical outcomes for indications with deep dermal involvement such as scars and striae. The goal of faster treatments can be met by delivering more energy per laser pulse. One of the optics described here, the Optic (Palomar Medical Technologies, Inc., Burlington, MA), contains a more efficient hexagonal array with an increase in microbeams per unit area and larger microbeam diameters than previous generation optics. Currently, available fractional technologies include either scanning or stamping devices. While scanning devices are associated with faster treatments, stamping devices enable parallel, contact cooling resulting in minimal epidermal involvement and reduced pain. The, with its unique microbeam array, combines speed with the advantages of skin contact cooling. For treatment of deeper dermal conditions, the XD Microlens combines cooling and tissue compression to overcome limitations inherent to wavelength selection, microbeam geometry, and energy. Briefly, wavelength absorption by the target chromophore (water) should be low enough to enable sufficient penetration of the tissue, yet high enough to permit selective photothermal coagulation. Attempts to increase depth of penetration by increasing microbeam energy also increases the diameters of the micro-columns causing greater epidermal injury and increased side effects. In addition, a saturation of column depth occurs that ultimately limits the maximum achievable depth. To improve the balance between maximal penetration with minimal epidermal involvement and side effects, the XD Microlens uses a contact mode of non-ablative treatment that combines cooling with tissue compression. Description of Optics The is a new optic designed for the 1540 Fractional Handpiece (Palomar Medical Technologies, Inc., Burlington, MA) that operates using the Palomar Icon Pulsed Light and Laser System. The optic is used in 1

a stamping mode while simultaneously delivering parallel cooling to the skin via a cooled sapphire window. The sapphire window houses a micro-lens array that separates a single large diameter beam from an Er:Glass laser into 175 micro-beams (Figure 1). Specifications for the optic are outlined in Table 1. Figure 1. Palomar 1540 XD Microlens The XD Microlens attaches to the 1540 Fractional Handpiece on the Palomar Icon Pulsed Light and Laser System. The sapphire contact window consists of a square array with 49 micro-pins each co-aligned with a microbeam and separated by 2 mm (Figure 2). Specifications for the optic are outlined in Table 1. Figure 2. Palomar 1540 XD Microlens Table 1 lists specifications for the Palomar Icon System s three 1540 nm fractional non-ablative handpiece optics. The standard 15 mm tip can be used for indications where less coverage and low depth is required and/ or when the risk of post-inflammatory hyperpigmentation (PIH) is elevated (e.g., in darker-skinned patients). Table 1. Specifications for 1540 fractional handpiece optics. 2

Ex Vivo Histology Material & Methods Porcine skin was warmed to physiologic temperatures and treated either with the at 50 mj/microbeam (mb), 15 ms or the XD Microlens at 70 mj/mb, 20 ms. treatments consisted of applying the optic to the skin and firing the laser. Treatments with the XD Microlens were performed by applying the optic to the skin with firm pressure and firing the laser after a predetermined compression time. Following both types of treatment, the tissue was biopsied and sectioned with a cryotome into 200 micron sections. Vertical tissue sections were stained with Nitroblue tetrazolium chloride (NBTC) and photographed to determine regions of cell viability loss. These regions were colocalized with regions of collagen coagulation (brighter regions). Horizontal sections were taken just below the epidermis and placed on a microscope slide with back lighting. laser firing. A typical treatment pass is laid out in horizontal rows and vertical columns with 50% overlap in the horizontal direction and 10% overlap (to avoid gaps) in the vertical direction. This means that the skin is treated twice in a single pass for approximately 12% coverage. XD Microlens Figure 4 depicts a cross-section of tissue following 2 seconds of compression using the 1540 nm fractional handpiece with the XD Microlens. The unstained, bright white region indicates the zone of coagulation. Compared to using the same handpiece and optic without compression, applying compression resulted in a nearly 50% increase in column depth and a simultaneous decrease in the diameter of the micro-column damage at the dermal/epidermal (D/E) junction. In addition, there was less separation of the D/E junction indicating less epidermal damage. Damage Profiles Figures 3A and 3B show the thermal injury profile in cross-sections perpendicular and parallel to the skin surface, respectively, following treatment. Viability staining (bluish-purple) of porcine dermis in Figure 3A shows a typical damage profile following treatment with the with the 1540 Fractional Handpiece at 50 mj/mb. The unstained portion indicates the region of collagen coagulation at a depth of 687 microns and width of 297 microns. Figure 3B demonstrates that the provides 6% coverage per Figure 4. Histology showing typical damage profiles following treatment with the 1540 nm fractional handpiece with the XD Microlens using 2 seconds of compression at 70 mj/mb. Figure 3. A) Histology showing typical damage profiles following treatment with the 1540 nm handpiece at 50 mj/mb with the XF Microlens. B) Typical damage profiles in a layer of dermis 200 microns thick located 200 microns beneath the epidermis. The image is back-illuminated such that bright regions represent regions of coagulated collagen caused by penetration of the microbeams. The spacing between micro-beams is 1 mm and the coverage is approximately 6%. Treatment parameters were 50 mj/mb at 15 ms. 3

Clinical Evaluations Preliminary clinical evaluations for each optic were performed to assess how well they met their respective objectives of faster treatment ( ) and deeper penetration with minimal epidermal involvement (XD Microlens ). The speed of treatment is determined by the desired coverage of treatment, the area to be treated and the optic s coverage rate. For fractional treatments, coverage is defined as the surface area of treatment-damaged (coagulated collagen) skin to total area. Table 2 summarizes the treatment time for the clinical indications of striae and surgical scars. Compared to the prior optic s lower coverage of 2.5% per pulse and longer treatment time (see Table 1), this new optic offers key advantages for treating larger anatomical areas. Figure 6 shows the appearance of the epidermal microinjury zones generated following treatment of the volar forearm in a Fitzpatrick Skin Type III subject. Three single pulses from the XD Microlens were delivered at 70 mj/mb using 0, 2, or 5 seconds of firm compression. Two days after treatment, the treated sites were photographed to measure the size of the epidermal micro-injury zones coincident with the micro-columns. These darkened zones, previously defined as micro-necrotic debris (MENDs ), were also seen in histology at this time point and were defined by a contiguous basal cell layer above which lies necrotic cellular debris and pigment presumed to be melanin or oxidized by-products. The epidermal injury zones were co-aligned with the underlying coagulated micro-columns in the papillary dermis. The effects of compression time on the diameter of the epidermal zones are shown in Figure 7. As compression time was increased from no compression time to 2 and 5 seconds, there was a 15% and 20% reduction, respectively, in the epidermal area involvement. Table 2. Approximate treatment times for striae and surgical scars using the. XD Microlens Histology shown in Figure 4 demonstrates the increased depth of penetration available with the XD Microlens ; however these depths must be carefully balanced against the optic s safety profile for realistic application. We investigated the relationship between compression time and the diameter of epidermal micro-injury zones to determine whether increased penetration resulted in increased epidermal injury zones. Figure 6. Epidermal micro-zones following treatment with the 1540 nm fractional handpiece and XD Microlens. Figure 5 shows the appearance of the skin following application of the XD Microlens using firm pressure. Figure 5. Human forearm skin showing impression of the XD Microlens. Figure 7. Differences in the diameters of the epidermal injury zone following various compression times. A 10% reduction in spot diameter translates to a 20% decrease in area of epidermal injury. Errors bars indicate ± standard deviation. 4

Conclusion Histology and preliminary clinical evaluations demonstrate the efficacy of the new and the XD Microlens in meeting the respective objectives of faster treatment coverage and deeper penetration with minimized epidermal involvement. The enables 6% treatment coverage per laser firing, with depths of coagulation of up to 700 microns in a single pulse. The fractional non-ablative XD Microlens delivers deeper penetration, up to 1.1 mm in a single pulse, and reduced involvement at the dermal/epidermal junction. Together, these optics provide flexibility for practitioners desiring fast treatment coverage, treatment of deeper indications such as surgical scars, acne scars, and striae and tailoring of treatment across a wide range of skin types. 5